These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15280922)

  • 1. Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
    Forsea AM; Müller C; Riebeling C; Orfanos CE; Geilen CC
    Br J Cancer; 2004 Aug; 91(4):803-10. PubMed ID: 15280922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates induce breast cancer cell death in vitro.
    Fromigue O; Lagneaux L; Body JJ
    J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
    Vorotnjak M; Boos J; Lanvers-Kaminsky C
    Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
    Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
    Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
    Hagelauer N; Pabst AM; Ziebart T; Ulbrich H; Walter C
    Clin Oral Investig; 2015 Jan; 19(1):139-48. PubMed ID: 24668343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
    Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA
    Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
    Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
    Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.
    Riebeling C; Forsea AM; Raisova M; Orfanos CE; Geilen CC
    Br J Cancer; 2002 Jul; 87(3):366-71. PubMed ID: 12177810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
    Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
    Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates induce apoptosis in human breast cancer cell lines.
    Senaratne SG; Pirianov G; Mansi JL; Arnett TR; Colston KW
    Br J Cancer; 2000 Apr; 82(8):1459-68. PubMed ID: 10780527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
    Shipman CM; Rogers MJ; Apperley JF; Russell RG; Croucher PI
    Br J Haematol; 1997 Sep; 98(3):665-72. PubMed ID: 9332325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2001 Jun; 12(5):459-65. PubMed ID: 11395574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells.
    Mansouri M; Mirzaei SA; Lage H; Mousavi SS; Elahian F
    Biochimie; 2014 Apr; 99():71-6. PubMed ID: 24287290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
    Boissier S; Ferreras M; Peyruchaud O; Magnetto S; Ebetino FH; Colombel M; Delmas P; Delaissé JM; Clézardin P
    Cancer Res; 2000 Jun; 60(11):2949-54. PubMed ID: 10850442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
    Fromigué O; Body JJ
    J Endocrinol Invest; 2002 Jun; 25(6):539-46. PubMed ID: 12109626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.
    Aparicio A; Gardner A; Tu Y; Savage A; Berenson J; Lichtenstein A
    Leukemia; 1998 Feb; 12(2):220-9. PubMed ID: 9519785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
    Mönkkönen H; Kuokkanen J; Holen I; Evans A; Lefley DV; Jauhiainen M; Auriola S; Mönkkönen J
    Anticancer Drugs; 2008 Apr; 19(4):391-9. PubMed ID: 18454049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bisphosphonates on the rapidly growing male murine skeleton.
    Zhu ED; Louis L; Brooks DJ; Bouxsein ML; Demay MB
    Endocrinology; 2014 Apr; 155(4):1188-96. PubMed ID: 24422540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt.
    Bezzi M; Hasmim M; Bieler G; Dormond O; Rüegg C
    J Biol Chem; 2003 Oct; 278(44):43603-14. PubMed ID: 12933798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.